1. The plaintiff (appointed party)'s claim is all dismissed.

2. The costs of lawsuit shall be borne by the plaintiff (appointed party).

1. Basic facts

A. The parties are corporations operating the F Hospital (hereinafter “Defendant Hospital”). The Plaintiff, the designated parties D, and the Defendant were children of the deceased G (H students, hereinafter “the deceased”), who died on May 23, 2016, while being diagnosed as food cancer by the Lee In-In-Post of the Defendant Hospital on February 26, 2015, and were receiving treatment. The designated parties C are the deceased’s spouse.

B. On February 26, 2015, the deceased’s surgery and treatment 1 deceased was diagnosed with food cancer at the Defendant Hospital on the same year.

3. The same year after undergoing food assistance, 11. Gibydo and clibly clibly and clibly clibly;

4.2. The Defendant Hospital was discharged.

2. On April 5, 2015, the Deceased was hospitalized in the Defendant Hospital to receive radiation treatment and anti-corropic cancer treatment, and the same year.

6.8. The blood species department of the Defendant Hospital was charged before Ebinology department.

3) 당시 망인은 방사선 치료와 항암 치료로 백혈구 수치가 감소하는 등 면역력이 저하된 상태였고, 피고 병원 혈액종양내과 의료진은 이비인후과 의료진에게 절대호중구 수치 백혈구 중 호중구의 수를 의미하는데, 호중구는 백혈구의 50~70%를 차지한다. 가 2,000/㎕ 이상 오를 때까지 2일에 한 번씩 혈액검사(CBC, Complete Blood Count) 혈액 내 존재하는 적혈구, 백혈구, 혈소판에 대한 정보를 제공하는 검사. 를 실시하고, 2,000/㎕ 이상 오르면 주 2회 혈액검사를 시행할 것을 권고하였다. 4) 피고 병원 의료진(이하 ‘피고 의료진’이라 한다)이 2015. 6. 18. 실시한 망인에 대한 혈액검사 결과 백혈구 수치는 3,550/㎕(정상 4,000~10,000/㎕), 호중구 수치는 2,280/㎕, 중성구 수치는 2,280/㎕(정상 1,900 ~ 8,000/㎕), 혈소판 수치는 241,000/㎕(정상 150~450k/㎕), CRP(C-반응성 단백질 검사) 수치는 36.1mg /L(정상 범위 0-3.0mg /L)로 나타났다.

5 The Deceased was transferred to the I Hospital on June 24, 2015, and it is difficult for the Deceased to drive with light pain, and food is not potable.